Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Findings from Baylor College of Medicine, College of Medicine advance knowledge in breast cancer
April 15th, 2008
In this recently published article, scientists in the United States conducted a study "To prospectively demonstrate the feasibility of using indocyanine green, a near-infrared (NIB) fluorophore at the minimum dose needed for noninvasive optical imaging of lymph nodes (LNs) in breast cancer-patients undergoing sentinel lymph node mapping (SLNM). Informed consent was obtained from 24 women (age range, 30-85 years) who received intradermal subcutaneous injections of 0.31 -100 mu g indocyanine green in the breast in this IRB-approved, HIPAA-compliant, dose escalation study to find the minimum microdose for imaging." "The breast, axilla, and sternum were illuminated with...
Source: Cancer Weekly (2008-04-15)
|
